Rate of Complete Virologic Response at 12 Month and Associated Factors Among Chronic Hepatitis B Patients Treated With Tdf In Tash From 2019-2023

Simple item page
dc.contributor.advisorAbdulsemed Mohammed
dc.contributor.authorTigistGeres
dc.date.accessioned2026-06-22T15:52:58Z
dc.date.available2026-06-22T15:52:58Z
dc.date.issued2025-04-15
dc.description.abstractChronic hepatitis B is a significant public health problem in sub-Saharan Africa, including Ethiopia. Despite the availability of antiviral therapies, achieving complete virological response could be challenged by several factors, including limited healthcare access, co-infections, and poor treatment adherence
dc.identifier.urihttps://etd.aau.edu.et/handle/123456789/8439
dc.language.isoen_US
dc.publisherAddis Ababa University
dc.subjectRate of Complete Virologic Response at 12 Month
dc.titleRate of Complete Virologic Response at 12 Month and Associated Factors Among Chronic Hepatitis B Patients Treated With Tdf In Tash From 2019-2023
dc.typeThesis

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
TigistGeresu.pdf
Size:
1.55 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download

Collections

Internal Medicine